Van Berkom & Associates Inc.

CIK 0001524408 · MONTREAL, A8 · Quarter end: 2026-06-30 · Filed on: 2026-08-05 · Open the SEC source

Van Berkom & Associates Inc. reported 67 positions worth $3.1M as of June 30, 2026 (13F filed August 5, 2026). Largest holding: VCTR (3.3%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$3.1M
2026 Q2
Positions
67
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
30.5%
Est. Net Flow (Q)
2026 Q2
10 / 67 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1VCTRVICTORY CAP HLDGS INC. COM CL ASH$102.9K3.32%1,224,567
2CRLCHARLES RIVER LABORATORIESSH$101.9K3.28%449,414
3ENSGENSIGN GROUP INC.SH$99.9K3.22%623,502
4LAURLAUREATE EDUCATION INC.SH$99.1K3.19%2,727,172
5DOCNDIGITALOCEAN HLDGS INC.SH$96.5K3.11%614,434
6PRVAPRIVIA HEALTH GROUP INCSH$95.5K3.08%3,711,623
7SNEXSTONEX GROUP INC.SH$88.4K2.85%745,686
8FSSFEDERAL SIGNAL CORP.SH$87.6K2.82%682,045
9PNTGPENNANT GROUP INC.SH$87.5K2.82%2,369,269
10G39108108GATES INDL CORP PLC ORD SHSSH$86.9K2.80%3,107,571

The free plan shows the top 10 positions. The remaining 57 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Van Berkom & Associates Inc. hold as of Q2 2026?

Van Berkom & Associates Inc. reported 67 positions worth $3.1M in its Q2 2026 13F filing. Largest positions: VCTR (3.3%), CRL (3.3%), ENSG (3.2%), LAUR (3.2%) and DOCN (3.1%).

What did Van Berkom & Associates Inc. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Van Berkom & Associates Inc. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.